Skip to main content
RDHL filings

Corporate insider profile

Gilead Raday Filing Activity

Latest reported as Chief Operating Officer of RedHill Biopharma Ltd. (RDHL).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,574.00
Latest transaction
Apr 6, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 6, 2026RedHill Biopharma Ltd. (RDHL)Chief Operating OfficerSale15,740,000$0.00$1,574